Sleep Hygiene Education in Type 2 Diabetes
The Effect of Sleep Hygiene Education on Sleep Quality and Glycemic Control in Patients With Type 2 Diabetes
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Izmir, Turkey (Türkiye)
- Dokuz Eylul University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosed with type 2 diabetes mellitus for at least 1 year
- Aged 18-65 years
- Pittsburgh Sleep Quality Index (PSQI) score > 5
Exclusion Criteria:
- Use of sedative medications
- Working night shifts
- Receiving pharmacological or non-pharmacological treatment for a diagnosed -sleep disorder
- Dementia or psychiatric disorder due to an organic or general medical condition, or history of psychotic disorder or bipolar disorder
- Pregnancy
- Change in diet or diabetes treatment regimen during the study period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control Usual Care
Participants in the control arm receive usual care without any structured sleep hygiene education intervention.
They continue their routine diabetes management and follow-up as provided in standard clinical practice.
No additional behavioral or educational intervention related to sleep is administered during the study period.
|
|
|
Experimental: İntervention
Participants in this arm receive a structured sleep hygiene education program in addition to usual diabetes care.
The education includes guidance on sleep-wake routines, sleep environment optimization, caffeine and screen use reduction, and behavioral strategies to improve sleep quality.
The intervention is delivered through standardized educational sessions and written materials
|
Participants in this arm receive a structured sleep hygiene education program in addition to usual diabetes care.
The education includes guidance on sleep-wake routines, sleep environment optimization, caffeine and screen use reduction, and behavioral strategies to improve sleep quality.
The intervention is delivered through standardized educational sessions and written materials.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Sleep Quality (Pittsburgh Sleep Quality Index, PSQI)
Time Frame: 3 Months
|
Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI).
The primary endpoint is the change in PSQI total score from baseline to post-intervention (end of follow-up), with lower scores indicating better sleep quality.
|
3 Months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Glycemic Control (HbA1c)
Time Frame: 3 Months
|
Glycemic control will be assessed using glycated hemoglobin (HbA1c, %).
The secondary outcome is the change in HbA1c levels from baseline to post-intervention (end of follow-up).
|
3 Months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2021/18-18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.